337 related articles for article (PubMed ID: 15885796)
1. Glutamate release induced by activation of glycine and GABA transporters in spinal cord is enhanced in a mouse model of amyotrophic lateral sclerosis.
Raiteri L; Zappettini S; Stigliani S; Paluzzi S; Raiteri M; Bonanno G
Neurotoxicology; 2005 Oct; 26(5):883-92. PubMed ID: 15885796
[TBL] [Abstract][Full Text] [Related]
2. Excessive and precocious glutamate release in a mouse model of amyotrophic lateral sclerosis.
Raiteri L; Stigliani S; Zappettini S; Mercuri NB; Raiteri M; Bonanno G
Neuropharmacology; 2004 May; 46(6):782-92. PubMed ID: 15033338
[TBL] [Abstract][Full Text] [Related]
3. Exocytosis regulates trafficking of GABA and glycine heterotransporters in spinal cord glutamatergic synapses: a mechanism for the excessive heterotransporter-induced release of glutamate in experimental amyotrophic lateral sclerosis.
Milanese M; Bonifacino T; Fedele E; Rebosio C; Cattaneo L; Benfenati F; Usai C; Bonanno G
Neurobiol Dis; 2015 Feb; 74():314-24. PubMed ID: 25497732
[TBL] [Abstract][Full Text] [Related]
4. Activation of a glycine transporter on spinal cord neurons causes enhanced glutamate release in a mouse model of amyotrophic lateral sclerosis.
Raiteri L; Paolucci E; Prisco S; Raiteri M; Bonanno G
Br J Pharmacol; 2003 Mar; 138(6):1021-5. PubMed ID: 12684256
[TBL] [Abstract][Full Text] [Related]
5. In vitro activation of GAT1 transporters expressed in spinal cord gliosomes stimulates glutamate release that is abnormally elevated in the SOD1/G93A(+) mouse model of amyotrophic lateral sclerosis.
Milanese M; Zappettini S; Jacchetti E; Bonifacino T; Cervetto C; Usai C; Bonanno G
J Neurochem; 2010 Apr; 113(2):489-501. PubMed ID: 20132478
[TBL] [Abstract][Full Text] [Related]
6. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Function and Overexpression of Metabotropic Glutamate Receptors 1 and 5 in the Spinal Cord of the SOD1
Bonifacino T; Rebosio C; Provenzano F; Torazza C; Balbi M; Milanese M; Raiteri L; Usai C; Fedele E; Bonanno G
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540330
[TBL] [Abstract][Full Text] [Related]
8. Group I metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis.
Giribaldi F; Milanese M; Bonifacino T; Anna Rossi PI; Di Prisco S; Pittaluga A; Tacchetti C; Puliti A; Usai C; Bonanno G
Neuropharmacology; 2013 Mar; 66():253-63. PubMed ID: 22634363
[TBL] [Abstract][Full Text] [Related]
9. Altered mechanisms underlying the abnormal glutamate release in amyotrophic lateral sclerosis at a pre-symptomatic stage of the disease.
Bonifacino T; Musazzi L; Milanese M; Seguini M; Marte A; Gallia E; Cattaneo L; Onofri F; Popoli M; Bonanno G
Neurobiol Dis; 2016 Nov; 95():122-33. PubMed ID: 27425885
[TBL] [Abstract][Full Text] [Related]
10. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
[TBL] [Abstract][Full Text] [Related]
11. GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis.
Carunchio I; Mollinari C; Pieri M; Merlo D; Zona C
Eur J Neurosci; 2008 Oct; 28(7):1275-85. PubMed ID: 18973555
[TBL] [Abstract][Full Text] [Related]
12. Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis.
Milanese M; Zappettini S; Onofri F; Musazzi L; Tardito D; Bonifacino T; Messa M; Racagni G; Usai C; Benfenati F; Popoli M; Bonanno G
J Neurochem; 2011 Mar; 116(6):1028-42. PubMed ID: 21175617
[TBL] [Abstract][Full Text] [Related]
13. Regulation of system x(c)- in the SOD1-G93A mouse model of ALS.
Albano R; Liu X; Lobner D
Exp Neurol; 2013 Dec; 250():69-73. PubMed ID: 24041987
[TBL] [Abstract][Full Text] [Related]
14. Activation of gamma-aminobutyric acid GAT-1 transporters on glutamatergic terminals of mouse spinal cord mediates glutamate release through anion channels and by transporter reversal.
Raiteri L; Stigliani S; Patti L; Usai C; Bucci G; Diaspro A; Raiteri M; Bonanno G
J Neurosci Res; 2005 May; 80(3):424-33. PubMed ID: 15789377
[TBL] [Abstract][Full Text] [Related]
15. Glycine receptor channels in spinal motoneurons are abnormal in a transgenic mouse model of amyotrophic lateral sclerosis.
Chang Q; Martin LJ
J Neurosci; 2011 Feb; 31(8):2815-27. PubMed ID: 21414903
[TBL] [Abstract][Full Text] [Related]
16. Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis.
Dunlop J; Beal McIlvain H; She Y; Howland DS
J Neurosci; 2003 Mar; 23(5):1688-96. PubMed ID: 12629173
[TBL] [Abstract][Full Text] [Related]
17. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Krishnan J; Vannuvel K; Andries M; Waelkens E; Robberecht W; Van Den Bosch L
J Neurochem; 2008 Sep; 106(5):2170-83. PubMed ID: 18624915
[TBL] [Abstract][Full Text] [Related]
18. Glycine taken up through GLYT1 and GLYT2 heterotransporters into glutamatergic axon terminals of mouse spinal cord elicits release of glutamate by homotransporter reversal and through anion channels.
Raiteri L; Stigliani S; Siri A; Passalacqua M; Melloni E; Raiteri M; Bonanno G
Biochem Pharmacol; 2005 Jan; 69(1):159-68. PubMed ID: 15588724
[TBL] [Abstract][Full Text] [Related]
19. Altered development in GABA co-release shapes glycinergic synaptic currents in cultured spinal slices of the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Medelin M; Rancic V; Cellot G; Laishram J; Veeraraghavan P; Rossi C; Muzio L; Sivilotti L; Ballerini L
J Physiol; 2016 Jul; 594(13):3827-40. PubMed ID: 27098371
[TBL] [Abstract][Full Text] [Related]
20. In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1
Bonifacino T; Provenzano F; Gallia E; Ravera S; Torazza C; Bossi S; Ferrando S; Puliti A; Van Den Bosch L; Bonanno G; Milanese M
Neurobiol Dis; 2019 Sep; 129():79-92. PubMed ID: 31102766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
